arrow
S

Susanne Merkel

University Hospital Erlangen
H指数:50
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma

术后循环单核细胞的重塑识别非经典单核细胞上CD86表达为胰腺导管腺癌的预后指标

2026-06-010
OAAI
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma

胰腺导管腺癌中CD44的免疫细胞特异性及异构体选择性调控,将淋巴结变异体丢失和囊泡CD44与胰腺导管腺癌的临床结局联系起来

Cells
IF5.2
2026-02-270
OA
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients

循环单核细胞及其亚群中Herpesvirus Entry Mediator表达的增加预示着胰腺导管腺癌患者的不良预后。

2025-03-210
OA
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

外泌体CD40、CD25和血清CA19-9作为胰腺导管腺癌患者诊断和预后的组合新型液体活检生物标志物

2025-02-110
OA
AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes

AMIGO2表征转移性结肠癌中与癌症相关的成纤维细胞,并诱导旁分泌活性致瘤性分泌物的释放

2024-11-110
OA
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients
2024-09-100
OAAI
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival
2024-05-232
OAAI
N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy
2023-03-0122
OAAI